Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (4): 680-685. doi: 10.19723/j.issn.1671-167X.2022.04.016
Previous Articles Next Articles
Min QIU1,Yan-yan LIAN2,Min LU3,Bin-shuai WANG1,Xiao-jun TIAN1,Jian LU1,Cheng LIU1,*(),Shu-dong ZHANG1,Min JIANG4,Lu-lin MA1,*()
CLC Number:
1 |
Matzkin H , Braf Z . Multiple primary malignant neoplasms in the genitourinary tract: Occurrence and etiology[J]. J Urol, 1989, 142 (1): 1- 12.
doi: 10.1016/S0022-5347(17)38649-4 |
2 |
宋航, 邱敏, 卢剑, 等. 合并肾癌的多原发癌诊断与治疗[J]. 北京大学学报(医学版), 2016, 48 (5): 926- 929.
doi: 10.3969/j.issn.1671-167X.2016.05.034 |
3 | Warren S , Gates O . Multiple primary malignant tumor A surgery of the literature and statistical study[J]. Am J Cancer, 1932, 51 (16): 1358- 1414. |
4 |
Moertel CG , Dockerty MB , Baggenstoss AH . Multiple primary malignant neoplasms. Ⅰ. Introduction and presentation of data[J]. Cancer, 1961, 14, 221- 230.
doi: 10.1002/1097-0142(196103/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6 |
5 |
Feller A , Matthes KL , Bordoni A , et al. The relative risk of second primary cancers in Switzerland: A population-based retrospective cohort study[J]. BMC Cancer, 2020, 20 (1): 51- 65.
doi: 10.1186/s12885-019-6452-0 |
6 |
Tanjak P , Suktitipat B , Vorasan N , et al. Risks and cancer associations of metachronous and synchronous multiple primary can-cers: A 25-year retrospective study[J]. BMC Cancer, 2021, 21 (1): 1045- 1054.
doi: 10.1186/s12885-021-08766-9 |
7 |
El-Taji O , Al-Mitwalli A , Malik F , et al. Secondary neoplasms of the urinary bladder-clinical management and oncological outcomes[J]. Transl Androl Urol, 2021, 10 (6): 2427- 2434.
doi: 10.21037/tau-20-955 |
8 |
Beisland C , Talleraas O , Bakke A , et al. Multiple primary malignancies in patients with renal cell carcinoma: A national population-based cohort study[J]. BJU Int, 2006, 97 (4): 698- 702.
doi: 10.1111/j.1464-410X.2006.06004.x |
9 |
Koh HM , An HJ , Ko GH , et al. Identification of myoferlin expression for prediction of subsequent primary malignancy in patients with clear cell renal cell carcinoma[J]. In Vivo, 2019, 33 (4): 1103- 1108.
doi: 10.21873/invivo.11579 |
10 |
Tian X , Xu WH , Wu JL , et al. Clear cell papillary renal cell carcinoma shares distinct molecular characteristics and may be significantly associated with higher risk of developing second primary malignancy[J]. Pathol Oncol Res, 2021, 27, 1609809.
doi: 10.3389/pore.2021.1609809 |
11 |
邱敏, 卢剑, 马潞林, 等. 透明细胞乳头状肾细胞癌的诊治经验[J]. 中华泌尿外科杂志, 2016, 37 (9): 655- 659.
doi: 10.3760/cma.j.issn.1000-6702.2016.09.004 |
12 |
Heo J , Noh O K , Oh Y , et al. Second primary cancer after liver transplantation in hepatocellular carcinoma: A nationwide population-based study[J]. Hepatol Int, 2017, 11 (6): 523- 528.
doi: 10.1007/s12072-017-9824-z |
13 |
Wang L , Wang H , Wang T , et al. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms[J]. Artif Cells Nanomed Biotechnol, 2019, 47 (1): 1101- 1112.
doi: 10.1080/21691401.2019.1575846 |
14 | Peng L , Zeng Z , Teng X , et al. Genomic profiling of synchronous triple primary tumors of the lung, thyroid and kidney in a young female patient: A case report[J]. Oncol lett, 2018, 16 (5): 6089- 6094. |
15 |
Keegan THM , Bleyer A , Rosenberg AS , et al. Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors[J]. JAMA Oncology, 2017, 3 (11): 1554- 1557.
doi: 10.1001/jamaoncol.2017.0465 |
16 |
Cho YY , Lim J , Oh C , et al. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: A nationwide, population-based study in Korea[J]. Cancer, 2015, 121 (2): 259- 268.
doi: 10.1002/cncr.29025 |
17 |
Joung JY , Kwon W , Lim J , et al. Second primary cancer risk among kidney cancer patients in Korea: A population-based cohort study[J]. Cancer Res Treat, 2018, 50 (1): 293- 301.
doi: 10.4143/crt.2016.543 |
18 | Etiz D , Metcalfe E , Akcay M . Multiple primary malignant neoplasms: A 10-year experience at a single institution from Turkey[J]. J Cancer Res Ther, 2017, 13 (1): 16- 20. |
[1] | Xiao-juan ZHU,Hong ZHANG,Shuang ZHANG,Dong LI,Xin LI,Ling XU,Ting LI. Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 243-253. |
[2] | Yu-mei LAI,Zhong-wu LI,Huan LI,Yan WU,Yun-fei SHI,Li-xin ZHOU,Yu-tong LOU,Chuan-liang CUI. Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 262-269. |
[3] | Qi SHEN,Yi-xiao LIU,Qun HE. Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 276-282. |
[4] | Qian SU,Xin PENG,Chuan-xiang ZHOU,Guang-yan YU. Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 13-21. |
[5] | Quan ZHANG,Hai-feng SONG,Bing-lei MA,Zhe-nan ZHANG,Chao-hui ZHOU,Ao-lin LI,Jun LIU,Lei LIANG,Shi-yu ZHU,Qian ZHANG. Pre-operative prognostic nutritional index as a predictive factor for prognosis in non-metastatic renal cell carcinoma treated with surgery [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 149-155. |
[6] | Xiao-yan XING,Jun-xiao ZHANG,Feng-yun-zhi ZHU,Yi-fan WANG,Xin-yao ZHOU,Yu-hui LI. Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1214-1218. |
[7] | Le-qing CAO,Jing-rui ZHOU,Yu-hong CHEN,Huan CHEN,Wei HAN,Yao CHEN,Yuan-yuan ZHANG,Chen-hua YAN,Yi-fei CHENG,Xiao-dong MO,Hai-xia FU,Ting-ting HAN,Meng LV,Jun KONG,Yu-qian SUN,Yu WANG,Lan-ping XU,Xiao-hui ZHANG,Xiao-jun HUANG. Relationship between treatment and prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1013-1020. |
[8] | Er-shu BO,Peng HONG,Yu ZHANG,Shao-hui DENG,Li-yuan GE,Min LU,Nan LI,Lu-lin MA,Shu-dong ZHANG. Clinicopathological features and prognostic analysis of papillary renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 615-620. |
[9] | Yu-han DENG,Yong JIANG,Zi-yao WANG,Shuang LIU,Yu-xin WANG,Bao-hua LIU. Long short-term memory and Logistic regression for mortality risk prediction of intensive care unit patients with stroke [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 458-467. |
[10] | LAN Lin,HE Yang,AN Jin-gang,ZHANG Yi. Relationship between prognosis and different surgical treatments of zygomatic defects: A retrospective study [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 356-362. |
[11] | WANG Fei,ZHU Xiang,HE Bei,ZHU Hong,SHEN Ning. Spontaneous remission of follicular bronchiolitis with nonspecific interstitial pneumonia: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1196-1200. |
[12] | Wei-bo GAO,Mao-jing SHI,Hai-yan ZHANG,Chun-bo WU,Ji-hong ZHU. Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 921-927. |
[13] | Mei-xiang ZHANG,Wen-zhi SHI,Jian-xin LIU,Chun-jian WANG,Yan LI,Wei WANG,Bin JIANG. Clinical characteristics and prognosis of MLL-AF6 positive patients with acute myeloid leukemia [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 915-920. |
[14] | Yan-fang JIANG,Jian WANG,Yong-jian WANG,Jia LIU,Yin PEI,Xiao-peng LIU,Ying-fang AO,Yong MA. Mid-to-long term clinical outcomes and predictors after anterior cruciate ligament revision [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 857-863. |
[15] | XIAO Ruo-tao,LIU Cheng,XU Chu-xiao,HE Wei,MA Lu-lin. Prognostic value of preoperative platelet parameters in locally advanced renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 647-652. |